학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 2,137건 | 목록 1~20
Academic Journal
d'Arminio Monforte, AntonellaTavelli, AlessandroRossotti, RobertoGagliardini, RobertaSaracino, AnnalisaLoundefinedCaputo, SergioSala, MatteoQuiros‐Roldan, EugeniaMussini, CristinaGirardi, EnricoCozzi‐Lepri, AlessandroAntinori, AndreaPuoti, MassimoA CostantiniA SaracinoE MilanoF MaggioloC SuardiE Quiros RoldanC MinardiB MenzaghiC AbeliL ChessaF PesB M CelesiaD ScuderiA PanP BrambillaG MazzarelloL A NicoliniM LichtnerA CarraroA ChioderaP MiliniG NunnariG PellicanòM PuotiC Uberti FoppaA De BonaS AntinoriC MoioliG MorsicaL GazzolaA GiacomelliI GentileF BorrelliC LazzarettiR CorsiniA AntinoriE GrilliL SarmatiE TetiR CaudaS La MonicaA CascioM TrizzinoD FrancisciE SchiaroliG MadedduA De VitoM FabbianiB RossettiM B PasticciC Di GiuliG StarniniA IalungoA d'Arminio MonforteA CastagnaG Di PerriE GirardiR IardinoA LazzarinG C MarchettiC MussiniE Quiros-RoldanB SuligoiF von SchloesserP VialeF Ceccherini-SilbersteinA CingolaniA Cozzi-LepriA GoriS Lo CaputoG MarchettiC F PernoC AgratiF BaiA BanderaS BonoraA CalcagnoD CanettiA CervoS CicaliniP CinqueA Di BiagioN GianottiG GuaraldiS LaniniG LapadulaA LaiV MalagninoS NozzaS PiconiC PinnettiR RossottiS RusconiM M SantoroV SpagnuoloN SquillaceV SvicherL TaramassoA VergoriF BovisI FantiA Rodano'M PonzanoA TavelliA BoveM CernuschiL CosmaroM ErricoA PerzianoV CalvinoS CarraraS GrazianoG ProtaS TruffaD VincentiY D'ErricoI A GiacomettiV BarocciC SantoroL BadiaS CretellaE M ErneA PieriE FocàP MaggiL AlessioB CacopardoB CelesiaJ VecchietS Dal ZoppoD SegalaF VichiDi PietroT SantantonioS FerraraM BassettiE PontaliS BlanchiN BobbioL FondacoC MolteniG CanavesiG RizzardiniV BonoM V CossuR LolattoM C MoioliL PezzatiC TincatiC PuzzolanteP BonfantiV SangiovanniV EspositoN CoppolaF M FuscoG Di FilippoV RizzoN SangiovanniS MartiniA M CattelanS MarinelloC ColombaG ParrutiF SozioP BlancA VivarelliM AndreoniC MastroianniV MazzottaS LamonicaM CapozziA MondiM Rivano CapparucciaG IaianiC StingoneL GianserraJ PaulicelliM M PlazziG d'EttoreM FustoM CecchettoF VivianiF MontagnaniA FrancoR Fontana Del VecchioB M PasticciG C OrofinoG CalleriG AccardoC TasciniA LonderoV ManfrinG BattaginD Farinacci
Liver International. 43:2130-2141
Academic Journal
Nicolini F; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Gaimari A; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, Cell Signalling Laboratory, University of Bologna, Bologna, Italy.; Mazzotti L; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, Cell Signalling Laboratory, University of Bologna, Bologna, Italy.; De Lucia A; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, Cell Signalling Laboratory, University of Bologna, Bologna, Italy.; Ghirelli M; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, Cell Signalling Laboratory, University of Bologna, Bologna, Italy.; Ancarani V; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Borges de Souza P; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Zurlo M; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Gazzola L; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, Cell Signalling Laboratory, University of Bologna, Bologna, Italy.; Magnoni C; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, Cell Signalling Laboratory, University of Bologna, Bologna, Italy.; Capobianco S; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, Cell Signalling Laboratory, University of Bologna, Bologna, Italy.; Angeli D; Unit of Biostatistics and Clinical Trials, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Bravaccini S; Department of Medicine and Surgery, University of Enna 'Kore', Enna, Italy.; Cerchione C; Hematology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Guidoboni M; Unità Operativa Complessa (UOC) Clinical Oncology, University Hospital of Ferrara, Ferrara, Italy.; Lanfrancone L; Department of Experimental Oncology, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) (IEO), Milan, Italy.; Marocchi F; Department of Experimental Oncology, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) (IEO), Milan, Italy.; Maltoni R; Healthcare Administration, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Tumedei MM; Department of Biomedical and Neuromotor Sciences, Cell Signalling Laboratory, University of Bologna, Bologna, Italy.; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Limarzi F; Pathology Unit, Morgagni-Pierantoni Hospital, Azienda Unità Sanitaria Locale (AUSL) Romagna, Forlì, Italy.; Pasini L; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Ridolfi L; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Mazza M; Advanced Cellular Therapies and Rare Tumors Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
IEEE Transactions on Software Engineering IIEEE Trans. Software Eng. Software Engineering, IEEE Transactions on. 45(1):34-67 Jan, 2019
Academic Journal
2022 IEEE Conference on Software Testing, Verification and Validation (ICST). :58-69
Academic Journal
Sethi M; Department of Otolaryngology, University Hospitals Birmingham, Birmingham, England.; Gowrishankar S; Department of Skull Base Surgery, Cambridge University Hospital, Cambridge, England.; Tysome J; Department of Skull Base Surgery, Cambridge University Hospital, Cambridge, England.; Donnelly N; Department of Skull Base Surgery, Cambridge University Hospital, Cambridge, England.; Axon P; Department of Skull Base Surgery, Cambridge University Hospital, Cambridge, England.; Bance M; Department of Skull Base Surgery, Cambridge University Hospital, Cambridge, England.; Mannion R; Department of Skull Base Surgery, Cambridge University Hospital, Cambridge, England.; Guilfoyle M; Department of Skull Base Surgery, Cambridge University Hospital, Cambridge, England.; Buttimore J; Department of Skull Base Surgery, Cambridge University Hospital, Cambridge, England.; Gamazo N; Department of Skull Base Surgery, Cambridge University Hospital, Cambridge, England.; Duke S; Department of Oncology, Cambridge University Hospital, Cambridge, England.; Jena R; Department of Oncology, Cambridge University Hospital, Cambridge, England.; Burton K; Department of Oncology, Cambridge University Hospital, Cambridge, England.; Jefferies S; Department of Oncology, Cambridge University Hospital, Cambridge, England.; Fornezza U; CyberKnife Stereotactic Neurosurgery Unit of Vicenza, Vicenza, Italy.; Perini Z; CyberKnife Stereotactic Neurosurgery Unit of Vicenza, Vicenza, Italy.; Mari C; CyberKnife Stereotactic Neurosurgery Unit of Vicenza, Vicenza, Italy.; Gazzola L; CyberKnife Stereotactic Neurosurgery Unit of Vicenza, Vicenza, Italy.; Schouten S; Department of Otorhinolaryngology, Dutch Academic Alliance Skull Base Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.; Compter I; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.; Eekers DBP; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.; Kunst HPM; Department of Otorhinolaryngology, Dutch Academic Alliance Skull Base Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.; Bassi R; Department of Otolaryngology-Head and Neck Surgery, Oxford University Hospitals, Oxford, England.; MacKeith S; Department of Otolaryngology-Head and Neck Surgery, Oxford University Hospitals, Oxford, England.; Jeyaretna S; Department of Neurosurgery, Oxford University Hospitals, Oxford, England.; Whitfield G; The Christie NHS Foundation Trust, Manchester, England.; McBain C; The Christie NHS Foundation Trust, Manchester, England.; Colaco R; The Christie NHS Foundation Trust, Manchester, England.; Hotchkies A; Salford Royal Foundation Trust, Salford, England.; Lloyd S; Salford Royal Foundation Trust, Salford, England.; Obholzer R; Department of Skull Base Surgery, King's College Hospital, London, England.; Cheang YFA; Department of Skull Base Surgery, King's College Hospital, London, England.; Thomas N; Department of Skull Base Surgery, King's College Hospital, London, England.; Barazi S; Department of Skull Base Surgery, King's College Hospital, London, England.; Maratos E; Department of Skull Base Surgery, King's College Hospital, London, England.; Shapey J; Department of Skull Base Surgery, King's College Hospital, London, England.; Hassan S; Department of Skull Base Surgery, King's College Hospital, London, England.; Tancu C; National Hospital for Neurology and Neurosurgery, London, England.; Kitchen N; National Hospital for Neurology and Neurosurgery, London, England.; Marinelli JP; Department of Skull Base Surgery, Mayo Clinic, Rochester, Minnesota.; Carlson ML; Department of Skull Base Surgery, Mayo Clinic, Rochester, Minnesota.; Link MJ; Department of Skull Base Surgery, Mayo Clinic, Rochester, Minnesota.; Borsetto D; Department of Otolaryngology, Cambridge University Hospitals, Cambridge, England.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101589542 Publication Model: Print Cited Medium: Internet ISSN: 2168-619X (Electronic) Linking ISSN: 21686181 NLM ISO Abbreviation: JAMA Otolaryngol Head Neck Surg Subsets: MEDLINE
Conference
2017 IEEE/ACM 39th International Conference on Software Engineering Companion (ICSE-C) ICSE-C Software Engineering Companion (ICSE-C), 2017 IEEE/ACM 39th International Conference on. :429-432 May, 2017
Academic Journal
Proceedings of the IEEE/ACM 1st International Conference on Automation of Software Test. :11-20
Academic Journal
De Lucia A; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Mazzotti L; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.; Gaimari A; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.; Zurlo M; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Maltoni R; Healthcare Administration, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Cerchione C; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Bravaccini S; Department of Medicine and Surgery, 'Kore' University of Enna, Enna, Italy.; Delmonte A; Medical Oncology Department, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Crinò L; Medical Oncology Department, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Borges de Souza P; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Pasini L; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Nicolini F; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Bianchi F; Unit of Cancer Biomarker, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, FG, Italy.; Juan M; Department of Immunology, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Calderon H; Department of Immunology, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Magnoni C; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.; Gazzola L; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.; Ulivi P; Translational Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Mazza M; Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Gazzola, L
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어